DE ROSA, Francesco Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 26.327
AS - Asia 15.405
EU - Europa 14.867
SA - Sud America 3.215
Continente sconosciuto - Info sul continente non disponibili 1.518
AF - Africa 536
OC - Oceania 173
AN - Antartide 1
Totale 62.042
Nazione #
US - Stati Uniti d'America 25.075
SG - Singapore 5.506
IT - Italia 5.462
CN - Cina 4.014
BR - Brasile 1.733
VN - Vietnam 1.628
FR - Francia 1.294
IE - Irlanda 1.164
DE - Germania 1.154
SE - Svezia 944
FI - Finlandia 835
KR - Corea 742
GB - Regno Unito 687
IN - India 616
DK - Danimarca 609
CA - Canada 587
HK - Hong Kong 494
UA - Ucraina 484
ES - Italia 459
PE - Perù 417
JP - Giappone 367
AR - Argentina 355
BD - Bangladesh 350
PL - Polonia 322
TR - Turchia 300
NL - Olanda 298
MX - Messico 288
CL - Cile 273
AT - Austria 260
ID - Indonesia 247
CO - Colombia 162
RU - Federazione Russa 157
AU - Australia 155
ZA - Sudafrica 136
BE - Belgio 130
IQ - Iraq 116
SA - Arabia Saudita 107
TH - Thailandia 105
EC - Ecuador 104
GR - Grecia 104
PK - Pakistan 102
IR - Iran 98
RO - Romania 92
TW - Taiwan 90
JM - Giamaica 86
EG - Egitto 80
PT - Portogallo 72
CR - Costa Rica 68
MA - Marocco 67
CH - Svizzera 62
PH - Filippine 54
PY - Paraguay 51
JO - Giordania 49
MY - Malesia 49
VE - Venezuela 49
TN - Tunisia 47
UZ - Uzbekistan 47
CZ - Repubblica Ceca 45
HN - Honduras 45
AE - Emirati Arabi Uniti 42
BO - Bolivia 40
IL - Israele 37
KE - Kenya 32
KZ - Kazakistan 32
LB - Libano 32
NI - Nicaragua 32
GT - Guatemala 30
NP - Nepal 29
UY - Uruguay 29
EU - Europa 28
TT - Trinidad e Tobago 28
ET - Etiopia 27
MN - Mongolia 27
NG - Nigeria 25
NO - Norvegia 25
DZ - Algeria 23
BG - Bulgaria 20
HU - Ungheria 20
LT - Lituania 20
QA - Qatar 20
SI - Slovenia 20
AZ - Azerbaigian 19
EE - Estonia 18
LV - Lettonia 18
NZ - Nuova Zelanda 17
PS - Palestinian Territory 16
HR - Croazia 14
RS - Serbia 14
UG - Uganda 14
BY - Bielorussia 13
MU - Mauritius 12
SY - Repubblica araba siriana 12
BA - Bosnia-Erzegovina 11
DO - Repubblica Dominicana 11
PR - Porto Rico 11
SV - El Salvador 11
AL - Albania 10
AP - ???statistics.table.value.countryCode.AP??? 10
BH - Bahrain 10
OM - Oman 10
Totale 60.362
Città #
Singapore 3.026
Ashburn 2.328
San Jose 1.881
Chandler 1.717
Beijing 1.641
Ann Arbor 1.372
Santa Clara 1.370
Dublin 1.150
Houston 737
Milan 707
Fairfield 693
Council Bluffs 470
Turin 460
Torino 459
Ho Chi Minh City 439
Villeurbanne 425
Los Angeles 420
Columbus 406
The Dalles 405
Dallas 404
Rome 396
Seoul 388
Princeton 382
Medford 379
Lauterbourg 375
Hong Kong 367
Hefei 360
Wilmington 348
Hanoi 331
Nyköping 327
Woodbridge 325
Jacksonville 294
Lima 289
Seattle 289
New York 274
Redwood City 259
Dearborn 254
Helsinki 251
Warsaw 246
Buffalo 243
Cambridge 221
Munich 207
Vienna 187
Tokyo 180
Pisa 178
Santiago 177
São Paulo 170
Jakarta 156
Boardman 153
Bengaluru 148
Boston 147
Guangzhou 136
Toronto 133
Verona 131
Dong Ket 130
Hangzhou 126
Shanghai 120
Frankfurt am Main 118
Fremont 114
Naples 113
Phoenix 113
Chicago 101
Bologna 96
Madrid 94
Atlanta 93
Sunnyvale 91
Florence 90
Lappeenranta 90
Nanjing 90
London 87
Brussels 86
Orem 86
San Diego 81
Nuremberg 80
Washington 80
Mexico City 79
Brooklyn 78
Montreal 78
Redondo Beach 77
Buenos Aires 75
Paris 74
Philadelphia 70
Turku 70
Amsterdam 67
Ankara 66
Hebei 65
Istanbul 65
Palermo 61
Johannesburg 60
Barcelona 58
Chennai 58
Rio de Janeiro 57
Bari 55
Genoa 55
Norwalk 55
Da Nang 54
Memphis 54
Silver Spring 54
San José 52
Kingston 49
Totale 32.876
Nome #
Pulmonary Echinococcosis or Lung Hydatidosis: A Narrative Review 2.114
Ceftolozane/tazobactam: place in therapy 1.784
Pharmacokinetics of linezolid during extracorporeal membrane oxygenation 1.040
Antimicrobial prophylaxis in minor and major surgery. 767
Intrathecal or intraventricular colistin: a review 561
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study 520
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 426
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. 423
Re-defining tigecycline therapy 403
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics? 391
Ceftriaxone bone penetration in patients with septic non-union of the tibia 376
Repurposed antiviral drugs for COVID-19 — InteriM WHO solidarity trial results 369
Ultra Performance Liquid Chromatography PDA Method for Determination of Tigecycline in Human Plasma. 336
Anidulafungin for Candida glabrata Infective Endocarditis 335
Effect of combination therapy containing a high dose carbapenem on mortality in patients with carbapenem-resistant klebsiella pneumoniae bloodstream infection 320
Three methods for estimating days of hospitalization because of hospital-acquired infection: a comparison 314
Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy 311
High rate of respiratory MDR gram-negative bacteria in H1N1-ARDS treated with ECMO. 310
Pharmacokinetics of anidulafungin in two critically ill patients with septic shock undergoing CVVH 306
Amikacin dosing in the ICU: we now know more, but still not enough… 301
Health-care Associated KPC-BSI: The Time Has Come. 297
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study 271
2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections 267
Antibiotic diffusion in pseudoarthrosic infected bone: glycopeptides, fluoroquinolones and carbapenems 264
Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome 264
Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication 261
Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation? 258
Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study 255
Antifungal Treatment Strategies in the ICU: Beyond Meta-analysis 254
SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4. 252
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship 247
Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia 245
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines. 245
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis 245
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. 243
A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection 241
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D 240
Elimination half-life may explain the relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1. 237
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting. 237
An unusual calf lesion in an immunocompromised patient. 233
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda. 229
Surgical antimicrobial prophylaxis prescribing practices and impact on infection risk: Results from a multicenter surveillance study in Italy (2012-2017) 229
Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS. 228
Start Smart with Antimicrobial Stewardship 223
PHISIOLOGIC VARIABLES AND PHARMCOKINETICS IMIPENEM DURING ENLP. A SINGLE CENTER TRANSPLANTATION EXPERIENCE 223
Effect of multidrug-resistant gene polymorphisms on daptomycin concentrations: preliminary results 222
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis 221
SLC29A1 −706G>C predict haemoglobin decrease in patients with hepatitis C treated with interferon and ribavirin 220
Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study 220
Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients 219
Osteomyelitis caused by Enterobacter cancerogenus infection following a traumatic injury: case report and review of the literature 218
The management of anti-infective agents in intensive care units: the potential role of a ‘fast’ pharmacology 218
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma. 214
Management of carbapenem-resistant K. pneumoniae in allogenic stem cell transplant recipients: the Turin bundle 211
The effect on mortality of fluconazole or echinocandins treatment in internal medicine wards 209
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge 208
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 207
Farmacocinetica dell’anidulafungina in pazienti con fibrosi cistica, trapianto epatico e emodiafiltrazione: dati preliminari. 206
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 206
Detection of Carbapenemase and CTX-M Encoding Genes Directly from Bronchoalveolar Lavage Using the CRE and ESBL ELITe MGB Assays: Toward Early and Optimal Antibiotic Therapy Management of Critically Ill Patients with Pneumonia 206
From ESKAPE to ESCAPE, From KPC to CCC. 205
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 205
Pharmacokinetics of Meropenem in Burn Patients with Infections Caused by Gram Negative Bacteria: Are We Getting Close to the Right Treatment? 204
V348I mutation in UL23 gene of human herpesvirus 1 in a case of herpetic hepatitis and haemophagocytic lymphohistiocytosis 203
Wound botulism after traumatic open fracture in Italy 202
Effect of combined renin angiotensin aldosterone inhibitors and diuretic treatment among patients hospitalized with SARS-CoV-2 Infection COVID-19 201
Mortality in early- and late-onset candidemia 200
New cephalosporins for the treatment of pneumonia in internal medicine wards 200
A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold 198
Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients 198
Infective endocarditis in the real world: the Italian Registry of Infective Endocarditis (Registro Italiano Endocardite Infettiva - RIEI). 198
Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots. 196
A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: Beyond the ICU 196
Clinical significance of pharmacokinetics of ertapenem in an outpatient setting 195
Clinical epidemiology in Italian Registry of Infective Endocarditis (RIEI): Focus on age, intravascular devices and enterococci 192
Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry 192
A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring 189
Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience 188
Prophylaxis drug monitoring of itraconazole and voriconazole in the paediatric onco-haematological setting 185
Influenza dei polimorfismi C3453T, C1236T, G2677T/A del gene MDR1 sulle concentrazioni plasmatiche di daptomicina 185
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 185
[Ertapenem. A new carbapenem in a single dose for community acquired infection] 184
Farmacocinetica della caspofungina in pazienti sottoposti a trapianto epatico. 184
Bacterial and Viral Infection and Sepsis in Kidney Transplanted Patients 182
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants 181
Prophylactic drug monitoring of itraconazole in an oncohematological pediatric patient population. 179
Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia 179
A retrospective study of viral central nervous system infections: relationship amongst aetiology, clinical course and outcome 178
Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 Patients: Keep an eye on the ball 177
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. 174
GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Brain Abscesses. Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses. 174
Carbapenemase-producing klebsiella pneumoniae colonization and infection in solid organ transplant recipients: A single-center, retrospective study 173
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus 172
COVID-19: A Possible Contribution of the MAPK Pathway 171
Antibiotic de-escalation experience in the setting of emergency department: A retrospective, observational study 169
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 168
Validation and Clinical Application of a New Liquid Chromatography Coupled to Mass Spectrometry (HPLC-MS) Method for Dalbavancin Quantification in Human Plasma 167
Cost‐effectiveness analysis of the prophylactic use of ertapenem for the prevention of surgical site infections after elective colorectal surgery 165
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections 164
Molecular characterization of toxigenic Clostridium difficile in a northern Italian hospital. 163
Totale 28.521
Categoria #
all - tutte 193.838
article - articoli 0
book - libri 0
conference - conferenze 8.879
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.913 0 0 0 383 350 392 364 290 259 263 746 866
2022/20236.480 702 465 318 526 586 1.443 446 456 626 223 379 310
2023/20243.603 394 571 198 249 305 342 180 233 108 264 304 455
2024/20258.967 261 533 478 701 1.636 669 350 511 919 673 789 1.447
2025/202619.383 1.701 1.133 1.249 2.271 1.874 913 2.422 871 1.503 1.568 938 2.940
2026/20275.269 958 1.675 1.640 996 0 0 0 0 0 0 0 0
Totale 62.042